Stocks TelegraphStocks Telegraph
Stock Ideas

AMBBY Company Profile and Key Details

PNK : AMBBY

Ambu A/S

$18.62
00
At Close 4:00 PM

Price Chart

Stock Price Today

Ambu A/S (AMBBY) stock remained unchanged at $11.00 a share on OTC. The stock opened at $10.82, fluctuating between $10.82 to $11.00 during the session.

Stock Snapshot

11
Prev. Close
2.92B
Market Cap
10.82
Day Low
36.97
P/E Ratio
0.29754
EPS (TTM)
1.88
Cash Flow per Share
10.82
Open
265.8M
Number of Shares
11
Day High
64.86%
Free Float in %
20.36
Book Value
19
Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing DateAccepted Date

Annual Report (10-k)

Filing DateAccepted Date

Stock Price History Chart

DateOpenHighLowCloseVolume
Sep 04, 202610.8210.8810.8210.8819
Sep 03, 202611.1711.1711.1711.1760
Sep 02, 202611.2011.2011.2011.208
Aug 31, 202610.4710.4710.4710.479
Aug 28, 202611.0011.0011.0011.001.01K
Aug 27, 202611.0711.2411.0711.2453
Aug 26, 202610.5110.5810.5110.581.02K
Aug 18, 202611.6511.6511.6511.652K
Aug 12, 202611.6111.6111.6111.6110
Aug 11, 202611.5711.5711.5711.575
Jul 28, 202610.8610.8610.8610.86500
Jul 20, 202610.5110.5110.5110.51102
Jul 01, 20269.709.709.709.701K
Jun 29, 20269.389.389.389.38600
Jun 25, 20269.439.439.439.43750
Jun 24, 20268.558.558.558.55151
Jun 22, 20269.519.519.519.51415
Jun 17, 20269.519.519.519.51100
Jun 12, 20269.749.749.709.70303
Jun 10, 20269.799.799.799.79435

Contact Details

Ballerup, CR 2750

Denmark

https://www.ambu.com457 225 2000

About Company

Ambu A/S engages in the development, production, and marketing of diagnostic and life-supporting devices for hospitals and rescue services. It operates through the following segments: Anaesthesia; Patient Monitoring & Diagnostics; and Visualisation. The Anaesthesia segment offers products from resuscitators, face masks, and laryngeal masks to the single use flexible intubation scope. The Patient Monitoring & Diagnostics segmet provides electrodes for cardiology, neurophysiology, and polysomnography. The Visualisation segment includes single-use visualisation devices, which are used in single lung ventilation procedure, or a bedside bronchoscopy procedure in the intensive care unit . The company was founded by Holger Hesse in 1937 and is headquartered in Ballerup, Denmark.

Company Information

Employees5384
Beta1.41
Sales or Revenue$6.04B
5Y Sales Change%0.709%
Fiscal Year EndsSeptember
SectorHealthcare
IndustryMedical - Devices

Technical Performance

Average 10-day trading volume of 29.00 shares is below the 3-month average of 427.42, indicating normal recent market interest.

Financial & Profitability Overview

Over the trailing twelve months, Ambu A/S generated $6.04B in revenue, or $22.61 per share. Gross margin was 55.97%, operating margin 12.99%, and net profit margin 10.09%. Returns are healthy, with ROA at 7.93% and ROE at 10.09%.
On valuation metrics, Ambu A/S trades at a P/E of 36.73, P/S of -1.01 and P/B of 3.06. The current ratio is 2.77 and quick ratio is 1.69. Operationally, the company’s inventory turnover is -5.94 and cash conversion cycle is -52.65 days , indicating it collects cash faster than it pays suppliers. Debt-to-equity is 0.09, supported by a cash flow-to-debt ratio of 1.65.

Quarterly Financial Highlights

For the quarter ended Sep 30, 2025, Ambu A/S posted revenue of $6.04B, down slightly from $5.39B in the prior quarter. Gross profit was $3.38B (margin 55.97%). Operating income was $784.00M (margin 13.0%). Net income was$609.00M (EPS $2.29).
The company ended the quarter with $866.00M in cash and short-term investments, a total debt of $547.00M, and net debt of - $319.00M. Total assets were $7.68B, with equity of $6.04B. Financials further reflected stability, with operating cash flow of $791.00M, free cash flow of $674.00M, and capital expenditures of - $117.00M.

Frequently Asked Questions

What is the current Ambu A/S (AMBBY) stock price?
Ambu A/S (OTC: AMBBY) stock price is $11.00 in the last trading session. During the trading session, AMBBY stock reached the peak price of $11.00 while $10.82 was the lowest point it dropped to. The percentage change in AMBBY stock occurred in the recent session was 0% while the dollar amount for the price change in AMBBY stock was $0.00.
AMBBY's industry and sector of operation?
The OTC listed AMBBY is part of Medical - Devices industry that operates in the broader Healthcare sector. Ambu A/S designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of AMBBY?
Mr. Henrik Ankjær
Executive Vice President of Global Operations
Mikkel Trier Wagner
Director of Corporation Communications
Mr. Bassel Rifai
Executive Vice President, Chief Marketing Officer & Pres APAC
Ms. Britt Meelby Jensen
Chief Executive Officer
Mr. Steven R. Block
Chief Executive Officer & Pres of USA
Mr. Thomas Frederik Schmidt
Executive Vice President & Chief Financial Officer
Mr. Anders F. Williamsson
Managing Director
Mr. Måns Barsne
Executive Vice President of Global Innovation & Chief Innovation Officer
Mr. Thomas Lykke Henriksen
Head of HR Systems
Holger Hesse
Founder
Mr. Nicolai Thomsen
Director of Investor Relations & Strategic Financial Planning
How AMBBY did perform over past 52-week?
AMBBY's closing price is 97.04% higher than its 52-week low of $8.55 where as its distance from 52-week high of $16.78 is -5.72%.
How many employees does AMBBY have?
Number of AMBBY employees currently stands at 5,384.
Link for AMBBY official website?
Official Website of AMBBY is: https://www.ambu.com
How do I contact AMBBY?
AMBBY could be contacted at phone 457 225 2000 and can also be accessed through its website. AMBBY operates from Baltorpbakken 13, Ballerup, CR 2750, Denmark.
How many shares of AMBBY are traded daily?
AMBBY stock volume for the day was 19 shares. The average number of AMBBY shares traded daily for last 3 months was 127.
What is the market cap of AMBBY currently?
The market value of AMBBY currently stands at $2.92B with its latest stock price at $11.00 and 265.8M of its shares outstanding.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph